ampicillin has been researched along with Bacterial Pneumonia in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (16.67) | 18.2507 |
| 2000's | 19 (39.58) | 29.6817 |
| 2010's | 20 (41.67) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, IK; Jeong, SH; Lee, SH; Lee, WG; Lee, YN | 1 |
| Nozawa, K; Sato, H; Sato, VH; Sugiyama, E; Suzuki, H; Suzuki, T; Tajima, M; Takahashi, K; Yoshii, M | 1 |
| Barraclough, R; Durviaux, S; Hessel, EM; Jackson, S; Kolsum, U; Maddi, S; Maschera, B; Pascal, TG; Simpson, KD; Singh, D | 1 |
| Djubailo, AV; Fatenkov, OV; Kuzmina, TM; Rubanenko, OA; Svetlova, GN | 1 |
| Carter, JM; Dorner, RA; Fajardo, M; Fricchione, M; Higgins, A; Marsden, L; Ryan, E | 1 |
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Fujita, J; Higa, F; Hiramatsu, K; Kadota, J; Kohno, S; Tateyama, M; Tokimatsu, I; Yamamoto, Y; Yanagihara, K | 1 |
| Marshall, S; Muto, C; Shoji, S; Soto, E; Tomono, Y | 1 |
| Bartlett, JA; Crump, JA; Maro, VP; Rubach, MP | 1 |
| Itamura, R; Kadota, J; Kohno, S; Mikamo, H; Niki, Y; Tateda, K | 1 |
| Averbuch, D; Blich, O; Breuer, O; Cohen-Cymberknoh, M; Kerem, E; Kharasch, S; Shoseyov, D | 1 |
| Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ | 1 |
| Çilli, A; Karaboğa, B | 1 |
| Ai, T; Deng, Q; Hu, J; Li, H; Liu, H; Liu, X; Wang, X; Xie, X; Yang, L; Yang, T; Yang, Z; Zhang, L; Zhang, T | 1 |
| Harasawa, K; Kagiyama, N; Kurashima, K; Matusita, F; Miyahara, Y; Saito, H; Sugita, Y; Takayanagi, N; Tokunaga, D; Ubukata, M; Yamaguchi, S; Yanagisawa, T; Yano, R; Yoneda, K | 1 |
| Higashiyama, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Nakamura, S; Seki, M; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Goulding, J; Hussell, T; Wissinger, E | 1 |
| Belet, N; Çiftçi, E; Doğru, Ü; Ince, E; Özdemir, H; Tapısız, A | 1 |
| Averbuch, D; Brooks, R; Cohen-Cymberknoh, M; Dinur-Schejter, Y; Kerem, E; Kharasch, S; Tenenbaum, A | 1 |
| Cambon, A; Kong, M; Smith, MJ; Woods, CR | 1 |
| Cantón Moreno, R; Castro, M; Del Campo, R; Girón, R; Gutiérrez, D; Máiz, L | 1 |
| Al-Khadra, ES; Barone, CP; Chau, KW; Colin, AA | 1 |
| Korppi, M | 1 |
| Dinur-Schejter, Y; Kerem, E; Kharasch, S | 1 |
| Ahmad, N; Ismail, IS; Kamsani, NH; Mohd-Zain, Z | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Asaoka, N; Fujita, K; Honda, N; Kurihara, T; Nakamura, J; Ohba, H; Okimoto, N | 1 |
| Gallaher, KJ; Pickett, KC | 1 |
| De Almeida, JF; De Sá, FR; Sztajnbok, J; Troster, EJ; Vaz, FA | 1 |
| Algorta, G; Ferrari, AM; Giachetto, G; Kaplan, SL; Martínez, A; Montano, A; Nanni, L; Pirez, MC | 1 |
| Marinella, MA | 1 |
| Fukuda, Y; Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Pommer, P | 1 |
| Asghar, R; Banajeh, S; Egas, J; Hibberd, P; Iqbal, I; Katep-Bwalya, M; Kundi, Z; Law, P; MacLeod, W; Maulen-Radovan, I; Mino, G; Qazi, S; Saha, S; Santosham, M; Sempertegui, F; Simon, J; Singhi, S; Thea, DM | 1 |
| Cepparulo, M; Ciliberti, G; Dal Farra, F; Ghelfi, R; Guelfi, R; Mancuso, I; Paris, R; Pirica, P; Pirina, P; Serra, G; Todisco, T | 1 |
| Betrosian, AP; Douzinas, EE; Frantzeskaki, F; Xanthaki, A | 1 |
| Puri, RK; Sachdev, HP; Satyanarayana, L; Vasanthi, B | 1 |
| Banke, S; Bruno, AM; Carlsson, M; Cronberg, S; Elmrud, H; Elowsson, S; Josefsson, K; Lindholm, AC; Montelius, H; Neringer, R | 1 |
| Klugman, KP | 1 |
| Kuruvilla, T; Prabhudesai, PP; Tadvi, S | 1 |
| Bédos, JP | 1 |
| Poirier, R | 1 |
| Chifu, S; Ebihara, M; Fukunaga, H; Furuno, T; Genka, K; Harada, Y; Hiraoka, T; Hirota, N; Inuyama, M; Ishibashi, T; Iwanaga, T; Kisanuki, K; Kishikawa, R; Makie, T; Matsukizono, K; Matsuura, Y; Mitsuno, T; Namba, K; Oe, T; Shimazu, K; Sugiyama, M; Takamoto, M; Tsumori, Y; Tsurutani, H; Ueno, Y | 1 |
| Maeda, S; Maeda, T; Nakamura, H; Yamada, Y | 1 |
| Kitada, H; Konishi, Y; Murakawa, K; Sakitani, H; Sasaki, Y; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Tsutsumi, M; Yoshimoto, M | 1 |
| Bogdanov, MB; Chernen'kaia, TV | 1 |
| Inase, N; Miyake, S; Sawabe, E; Yoshizawa, Y | 1 |
| Boucher, BA; Croce, MA; Fabian, TC; Hanes, SD; Wood, GC | 1 |
2 review(s) available for ampicillin and Bacterial Pneumonia
| Article | Year |
|---|---|
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Amoxicillin; Ampicillin; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Lactams; Moraxella catarrhalis; Neisseriaceae Infections; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumonia, Bacterial; Predictive Value of Tests; Streptococcus pneumoniae; Treatment Failure | 1996 |
[Bacterial pneumonia].
Topics: Ampicillin; Drug Resistance; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Penicillin G; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Reference Standards; Severity of Illness Index; Streptococcus pneumoniae; Time Factors | 2002 |
13 trial(s) available for ampicillin and Bacterial Pneumonia
| Article | Year |
|---|---|
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Sulbactam; Treatment Outcome | 2013 |
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Computer Simulation; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Female; Humans; Infusions, Intravenous; Japan; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pneumonia, Bacterial; Sulbactam | 2014 |
Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacteria; Community-Acquired Infections; Female; Humans; Japan; Male; Middle Aged; Pneumonia, Bacterial; Sputum; Sulbactam; Treatment Outcome; Young Adult | 2015 |
A clinical comparative study of piperacillin and sulbactam/ampicillin in patients with community-acquired bacterial pneumonia.
Topics: Aged; Aged, 80 and over; Ampicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Radiography; Sulbactam | 2009 |
Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Severity of Illness Index; Sulbactam; Treatment Outcome | 2006 |
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Topics: Ampicillin; Bacteremia; Child, Preschool; Chloramphenicol; Community-Acquired Infections; Developing Countries; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Male; Pneumonia, Bacterial; Treatment Failure | 2008 |
An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2008 |
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2008 |
Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
Topics: Amdinocillin; Ampicillin; Cefadroxil; Cefotaxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Pyelonephritis | 1995 |
Community-acquired pneumonia: need for a cost-effective approach to treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ampicillin; Community-Acquired Infections; Cost-Benefit Analysis; Developing Countries; Female; Hospitalization; Humans; India; Injections, Intravenous; Length of Stay; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Remission Induction | 1997 |
[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Ampicillin; Aspartate Aminotransferases; Cefotiam; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 1998 |
Efficacy of antibiotics against influenza-like illness in an influenza epidemic.
Topics: Acute Disease; Ampicillin; Bacterial Infections; Child, Preschool; Diarrhea; Disease Outbreaks; Drug Therapy, Combination; Female; Fever; Humans; Incidence; Influenza A virus; Influenza, Human; Japan; Male; Otitis Media; Pneumonia, Bacterial; Population Surveillance; Sulbactam; Urban Health | 1999 |
33 other study(ies) available for ampicillin and Bacterial Pneumonia
| Article | Year |
|---|---|
Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Pneumonia, Bacterial; Sequence Analysis, DNA | 2007 |
Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Injections, Intravenous; Male; Pneumonia, Bacterial; Renal Elimination; Retrospective Studies; Sulbactam; Treatment Outcome | 2021 |
Ampicillin resistance in
Topics: Aged; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Genotype; Haemophilus Infections; Haemophilus influenzae; Humans; Lung; Male; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sputum; Time Factors; United Kingdom | 2017 |
[Community acquired bacterial pneumonia and comorbidity in elderly patients].
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Female; Heart Failure; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2017 |
Gradenigo Syndrome and Cavitary Lung Lesions in a 5-Year-Old With Recurrent Otitis Media.
Topics: Abducens Nerve Diseases; Actinomycosis; Ampicillin; Anti-Bacterial Agents; Child, Preschool; Coinfection; Diagnosis, Differential; Fatigue; Fusobacterium Infections; Fusobacterium nucleatum; Gram-Positive Bacterial Infections; Humans; Male; Mastoiditis; Otitis Media; Peptostreptococcus; Pneumonia, Bacterial; Recurrence; Sulbactam; Syndrome; Trigeminal Neuralgia; Weight Loss | 2017 |
Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Ampicillin; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Child; Cohort Studies; Cryptococcosis; Emergencies; Female; Gentamicins; Histoplasmosis; Humans; Infections; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Distress Syndrome; Shock, Septic; Tanzania; Tetracycline; Young Adult | 2015 |
Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Female; Fever; Hospitalization; Humans; Infant; Length of Stay; Linear Models; Logistic Models; Male; Multivariate Analysis; Penicillins; Pneumonia, Bacterial; Retrospective Studies | 2015 |
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors | 2015 |
[Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia].
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam | 2015 |
[Multicenter prospective epidemiological studies on Haemophilus influenzae infection among hospitalized children with lower respiratory tract infections].
Topics: Ampicillin; beta-Lactamases; Child; Child, Hospitalized; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Epidemiologic Studies; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Polymerase Chain Reaction; Prospective Studies; Respiratory Tract Infections; Sepsis | 2016 |
[Case of pneumonia caused by beta-lactamase-producing and amoxicillin/clavulanate resistant strains of H. influenzae].
Topics: Aged, 80 and over; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumonia, Bacterial | 2008 |
Bacterial complications during pandemic influenza infection.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azithromycin; Cell Adhesion Molecules; Civil Defense; Disease Outbreaks; Epithelial Cells; Humans; Influenza, Human; Lung; Mice; Nasopharynx; Orthomyxoviridae; Pneumonia, Bacterial | 2009 |
Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia.
Topics: Adolescent; Ampicillin; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Odds Ratio; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Sulbactam; Treatment Failure; Turkey | 2011 |
Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Community-Acquired Infections; Hospitalization; Humans; Infant; Penicillins; Pneumonia, Bacterial; Retrospective Studies | 2013 |
Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Consensus; Drug Substitution; Drug Utilization; Evidence-Based Medicine; Female; Guideline Adherence; Hospitals, Pediatric; Humans; Infant; Inservice Training; Kentucky; Length of Stay; Logistic Models; Male; Patient Readmission; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Practice Patterns, Physicians'; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Maintenance treatment with inhaled ampicillin in patients with cystic fibrosis and lung infection due to methicillin-sensitive Staphylococcus aureus.
Topics: Administration, Inhalation; Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Disease Susceptibility; Drug Evaluation; Female; Follow-Up Studies; Haemophilus Infections; Haemophilus parainfluenzae; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Retrospective Studies; Superinfection; Young Adult | 2012 |
Invasive pneumonia and septic shock in infants as a presentation of cystic fibrosis with vitamin-deficiency.
Topics: Ampicillin; Anti-Bacterial Agents; Avitaminosis; Ceftazidime; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant; Male; Pneumonia, Bacterial; Respiration, Artificial; Respiratory Insufficiency; Shock, Septic; Tobramycin; Treatment Outcome | 2012 |
Intravenous penicillin--still the first-line therapy for pediatric community-acquired pneumonia.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Humans; Penicillins; Pneumonia, Bacterial | 2013 |
Reply: To PMID 22431471.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Humans; Penicillins; Pneumonia, Bacterial | 2013 |
Antibiotic susceptibility profile of Haemophilus influenzae and transfer of co-trimoxazole resistance determinants.
Topics: Ampicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Malaysia; Microbial Sensitivity Tests; Phenotype; Plasmids; Pneumonia, Bacterial; Serotyping; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
Topics: Aged; Aged, 80 and over; Ampicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Sulbactam | 2003 |
Facial submandibular cellulitis associated with late-onset group B streptococcal infection.
Topics: Ampicillin; Cellulitis; Diagnosis, Differential; Drug Therapy, Combination; Face; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus agalactiae; Vancomycin | 2004 |
Listeria monocytogenes pneumonia in a cirrhotic child.
Topics: Adolescent; Amikacin; Ampicillin; Anti-Bacterial Agents; Female; Humans; Listeria monocytogenes; Listeriosis; Liver Cirrhosis; Pleural Effusion; Pneumonia, Bacterial | 2004 |
Ampicillin and penicillin concentration in serum and pleural fluid of hospitalized children with community-acquired pneumonia.
Topics: Adolescent; Ampicillin; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Inpatients; Male; Penicillins; Pleural Effusion; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae | 2004 |
Community-acquired pneumonia due to Pasteurella multocida.
Topics: Aged; Ampicillin; Animals; Anti-Bacterial Agents; Cats; Community-Acquired Infections; Dogs; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Sulbactam; Zoonoses | 2004 |
[Risk classification in community-acquired pneumonia].
Topics: Amoxicillin; Ampicillin; Community-Acquired Infections; Confusion; Humans; Patient Admission; Pneumonia, Bacterial; Risk Assessment; Severity of Illness Index | 2006 |
Simple predictors to differentiate acute asthma from ARI in children: implications for refining case management in the ARI Control Programme.
Topics: Acute Disease; Ampicillin; Asthma; Bronchodilator Agents; Case-Control Studies; Child, Preschool; Cough; Diagnosis, Differential; Fever; Forecasting; Humans; Infant; Logistic Models; Pneumonia, Bacterial; Respiration; Respiratory Sounds; Respiratory Tract Infections; Sensitivity and Specificity | 1994 |
[Would ampicillin alone again be enough for treating community-acquired pneumonias?].
Topics: Adult; Ampicillin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial | 1998 |
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Haemophilus influenzae; Humans; Penicillin Resistance; Penicillins; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.
Topics: Adenocarcinoma; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Carcinogens; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cocarcinogenesis; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Drugs, Chinese Herbal; Erythromycin; Gene Expression Regulation; Inflammation; Lung Neoplasms; Macrophages; Male; Neutrophils; Nitrosamines; Penicillins; Piroxicam; Plant Extracts; Pneumonia, Bacterial; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis; Specific Pathogen-Free Organisms | 2000 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Inpatients; Penicillins; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.
Topics: Acinetobacter; Adult; Ampicillin; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Treatment Outcome; Ventilators, Mechanical | 2002 |